Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SAGE by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−1,356,577−100.0%Sold outHolders
Q2 20251,356,577$12.4M<0.1%+53,200+4.1%AddedHolders
Q1 20251,303,377$10.4M<0.1%+46,474+3.7%AddedHolders
Q4 20241,256,903$6.83M<0.1%+14,049+1.1%AddedHolders
Q3 20241,242,854$8.98M<0.1%+3,757+0.3%AddedHolders
Q2 20241,239,097$13.5M<0.1%+47,766+4.0%AddedHolders
Q1 20241,191,331$22.3M<0.1%+24,074+2.1%AddedHolders
Q4 20231,167,257$25.3M<0.1%+61,744+5.6%AddedHolders
Q3 20231,105,513$22.8M<0.1%+37,968+3.6%AddedHolders
Q2 20231,067,545$50.2M<0.1%+27,300+2.6%AddedHolders
Q1 20231,040,245$43.6M<0.1%+32,815+3.3%AddedHolders
Q4 20221,007,430$38.4M<0.1%+43,476+4.5%AddedHolders
Q3 2022963,954$37.7M<0.1%+9,581+1.0%AddedHolders
Q2 2022954,373$30.8M<0.1%+237,691+33.2%AddedHolders
Q1 2022716,682$23.7M<0.1%−191,547−21.1%ReducedHolders
Q4 2021908,229$38.6M<0.1%+33,424+3.8%AddedHolders
Q3 2021874,805$38.8M<0.1%+101,121+13.1%AddedHolders
Q2 2021773,684$44.0M<0.1%+116,220+17.7%AddedHolders
Q1 2021657,464$49.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.